Skip to main content
. 2003 Jun;47(6):2009–2011. doi: 10.1128/AAC.47.6.2009-2011.2003

TABLE 2.

Frequency of katG Ser315 codon mutations among 364 INH-resistant M. tuberculosis isolates determined by PCR-RFLP assay

Resistance patterna Case statusb No. of isolates with mutations/ total no. of isolates tested (%)d
H 13/26 (50)
New 7/17 (41.2)
Treated 6/9 (66.7)
H, R 13/23 (56.5)
New 7/9 (77.8)
Treated 6/14 (42.6)
H, S 32/39 (82.1)
New 27/32 (84.4)
Treated 5/7 (71.4)
H, E 1/1 (100)
New 1/1 (100)
Treated None
H, R, S 75/89 (84.3)
New 29/36 (80.6)
Treated 46/53 (86.9)
H, R, E 5/6 (83.3)
New 4/4 (100)
Treated 1/2 (50)
H, S, E 6/8 (75.0)
New 3/5 (60.0)
Treated 3/3 (100)
H, R, S, E 167/172 (97.1)
New 52/53 (98.1)
Treated 115/119 (96.6)
H, any 312/364 (85.7)
New 130/157 (82.8)
Treated 182/207 (87.9)
Multiple-drug resistant 299/338 (88.5)
New 123/140 (87.9)
Treated 176/198 (88.9)
MDRc 260/290 (89.7)
New 92/102 (90.2)
Treated 168/188 (89.4)
H, any; R sensitive 52/74 (70.3)
New 38/55 (69.1)
Treated 14/19 (73.7)
a

Drug resistance abbreviations: H, INH; R, RIF; S, STR; E, EMB. Any, resistant to any other drug.

b

New, isolates recovered from new cases of tuberculosis; treated, isolates recovered from previously treated cases of tuberculosis.

c

Resistant to both INH and RIF at least.

d

For each resistance pattern, the first entry is the total for new and previously treated cases.